Cefotaxime-induced Stevens-Johnson syndrome
Sandeep Lahiry
Asian Journal of Medical Sciences · 2016
doi:10.3126/ajms.v7i6.15594 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are severe cutaneous immune-complex hypersensitivity reactions. Drugs, especially sulfa drugs, antiepileptics, and antibiotics like cephalosporins, are the most common causes. Maculopapular lesions rapidly spread and coalesce, leading to epidermal blistering, necrosis, and sloughing. Diagnosis is usually obvious by appearance of initial lesions and clinical syndrome. Treatment is supportive care; cyclosporine, plasma exchange or IVIG, and early pulse corticosteroid therapy have been used. Mortality can be as high as 7.5% in children and 20 to 25% in adults but tends to be lower with early treatment.Here, we present a case of a 26year old female who presented with extensive dermal lesions and ocular findings including periorbital skin scarring, conjunctivitis with corneal erosions, as well as fever and prostration, soon after the administration of cefotaxime. Epidermal detachment was observed in <10% of her body surface. This presentation is consistent with the features of SJS. Resolution of the clinical manifestations was observed after discontinuation of the drug; all other drugs, infections, or immunologic disorders that could have caused this syndrome were carefully excluded. An objective causality assessment revealed that SJS was possibly associated with the use of cefotaxime.Asian Journal of Medical Sciences Vol.7(5) 2016 87-90
Abstract licence: CC BY-NC
References16
16 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.